Results 231 to 240 of about 100,430 (293)

Assessment of Perinatal Pelvic Floor Dysfunction Symptoms and Risk Factors: Measurement Properties of the International Consultation on Incontinence—Perinatal Pelvic Health Self‐Assessment Questionnaire (ICIQ‐PPHSAQ)

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Objective To assess the measurement properties of the International Consultation on Incontinence—Perinatal Pelvic Health Self‐Assessment Questionnaire (ICIQ‐PPHSAQ) and to identify symptom subscales for scoring. Design, Setting and Population Two cohorts of perinatal women (antenatal and postnatal) at nine NHS trusts in England completed ICIQ ...
Alan Uren   +19 more
wiley   +1 more source

Indications and Efficacy of Progestogen‐Monotherapy as Menopause Hormone Therapy: A Narrative Review

open access: yesBJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
ABSTRACT Menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms (VMS) and other manifestations of menopause; however, its use is limited in women with contraindications to oestrogen. Progestogen monotherapy, though historically underutilized, represents a viable alternative in this population. This narrative review
Chloe Thomas   +3 more
wiley   +1 more source

Therapeutic Value of Lactobacillus gasseri 345A in Chronic Constipation. [PDF]

open access: yesNeurogastroenterol Motil
Roos S   +7 more
europepmc   +1 more source

Content validation of the nursing diagnosis “Adult Disuse Syndrome”: A quantitative study

open access: yesInternational Journal of Nursing Knowledge, EarlyView.
Abstract Purpose This study aimed to establish the content validity of the proposed nursing diagnosis (ND) “Adult Disuse Syndrome” and all its components. Method This is an exploratory descriptive study of diagnostic content validation under Fehring's proposal.
Edinson Fabian Ardila‐Suárez   +2 more
wiley   +1 more source

Efficacy and Tolerability of Weekly Bortezomib, Lenalidomide, and Dexamethasone Protocols in Transplant‐Ineligible Newly Diagnosed Myeloma: An Australian Real‐World, Multicenter Study

open access: yesAsia-Pacific Journal of Clinical Oncology, EarlyView.
RVD with weekly bortezomib dosing in real‐world newly diagnosed transplant‐ineligible myeloma shows comparable efficacy and reduced toxicity compared to twice‐weekly trial protocols. ABSTRACT Background Lenalidomide, bortezomib, and dexamethasone (RVD) remains a standard of care regimen for newly diagnosed multiple myeloma in centers without access to ...
Samantha Kurniawan   +17 more
wiley   +1 more source

International Guideline on the Diagnosis and Management of Pediatric Patients With Hereditary Angioedema

open access: yesAllergy, EarlyView.
ABSTRACT Hereditary angioedema (HAE) with C1 inhibitor deficiency is a rare disease characterized by unpredictable episodes of tissue swelling (angioedema), which, in most cases, occur first under the age of 18 years, and entail a significant burden of disease not only for the patients but also for their families.
Henriette Farkas   +128 more
wiley   +1 more source

Home - About - Disclaimer - Privacy